Tarsus Pharmaceuticals, Inc. TARS Number of leases
Number of leases at other companies
Other financials
Where this comes from
Reported directly by Tarsus Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept tars:LesseeOperatingLeaseNumberOfLeaseContracts.
The official record: Tarsus Pharmaceuticals, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Tarsus Pharmaceuticals, Inc.'s number of leases.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Tarsus Pharmaceuticals, Inc.'s number of leases?
- Tarsus Pharmaceuticals, Inc. (TARS) reported number of leases of 2 in Q1 2026.
- How has Tarsus Pharmaceuticals, Inc.'s number of leases changed year-over-year?
- Tarsus Pharmaceuticals, Inc.'s number of leases decreased by 66.7% year-over-year, from 6 to 2.
- What is the long-term trend for Tarsus Pharmaceuticals, Inc.'s number of leases?
- Over 3 years (2022 to 2025), Tarsus Pharmaceuticals, Inc.'s number of leases has grown at a -20.6% compound annual growth rate (CAGR), from 4 to 2.
- What does number of leases mean?
- This count represents the total number of active operating lease agreements held by the company for facilities or equipment. It provides a high-level view of the company's operational footprint and the scale of its fixed contractual obligations.